erytromycine
J - Antiinfectives For Systemic Use -> J01 - Antibacterials For Systemic Use -> J01F - Macrolides, Lincosamides And Streptogramins -> J01FA - Macrolides -> J01FA01 - Erythromycin
Administration category:
Free
Medicine group:
antibacterial
Safety margins
| Weight | ROA | Dosage |
|---|---|---|
|
ROA: po |
Dosage: min. 250mg 4 dd to max. 1000mg 4 dd |
|
|
ROA: iv |
Dosage: min. 250mg 4 dd to max. 1000mg 4 dd |
Dosage for "I" sensitivity
| Weight | ROA | Load | Dosage |
|---|---|---|---|
|
ROA: po |
Load: - |
Dosage: 1000mg 4 dd |
|
|
ROA: iv |
Load: - |
Dosage: 1000mg 4 dd |
Kidney function
Renal elimination:
2-15%
Dosage:
independent on kidney function
Interactions
| Interaction with (ATC): | Expected effect: |
|---|---|
|
Interaction with (ATC): N03AF01 - Carbamazepine |
Expected effect: verhoging plasmaconcentratie carbamazepine |
|
Interaction with (ATC): L04AD01 - Ciclosporin |
Expected effect: verhoging concentratie ciclosporine |
|
Interaction with (ATC): L04AD02 - Tacrolimus |
Expected effect: verhoging concentratie tacrolimus |
|
Interaction with (ATC): L04AA10 - Sirolimus |
Expected effect: verhoging concentratie sirolimus |
|
Interaction with (ATC): R06AX12 - Terfenadine |
Expected effect: toename cardiotoxiciteit |
|
Interaction with (ATC): A03FA02 - Cisapride |
Expected effect: toename cardiotoxiciteit |
|
Interaction with (ATC): C01BA03 - Disopyramide |
Expected effect: toename cardiotoxiciteit |
|
Interaction with (ATC): C01AA05 - Digoxin |
Expected effect: verhoging plasmaconcentratie digoxine |
|
Interaction with (ATC): R03DA04 - Theophylline |
Expected effect: verhoging plasmaconcentratie theofylline |
|
Interaction with (ATC): J05AE - Protease Inhibitors |
Expected effect: verhoging plasmaconcentratie erytromycine |
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-1388.2
Updated: 03/21/2024 - 17:24
Status: Published
General comments
CVVH: Geen aanpassing van dosering nodig.